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eosinophil-derived neurotoxin, antineoplastic urinary protein, an-
giostatin, inhibin, and activin A. A tentative identification of the
presence of the peptide  defensin-1 in urine profiles in this study can
be made based on comparison with previous non-SELDI-based uri-
nary studies. Produced by many epithelial cell types including partic-
ularly the renal distal tubules and Loops of Henle in the kidney (40,
41), the presence of  defensin-1 in urine has been described previ-
ously (40, 42), with proforms and proteolytically processed forms
including of 5068.1, 5068.7, 4749.2, and 4750.5 Da, very close to the
masses of the peaks seen here at 5071.5 and 4753.3, and able to bind
WCX2 chips (43). The reason for the decrease or relative absence in
RCC urines may reflect increased proteolysis or alternatively de-
creased production, because complete loss of defensin expression has
been shown in clear cell tumors (44).
However, the most marked problem in the present study is the poor
results achieved with the subsequent larger blind set analyzed 10
months later, particularly the marked decline in sensitivity. There are
several possible explanations ranging from sample processing and
stability through machine performance to problems with the neural-
network model. The neural-network model was used in combination
with an equally promising peak detection algorithm that enabled the
explicit identification of predictively relevant peaks, in contrast with
the “black box” approaches often used in machine learning. As is
typical with neural-network analyses, various aspects of this design
were arrived at via a process of trial and error. Experimentation on
fictional data sets was used to establish that the network could
successfully classify cases given a few predictively relevant peaks
against a background of noise, and experimentation within the training
set determined the optimum number of inputs for each model type
with this number determining the sizes of models used to predict the
blind test sets. Peaks were ranked by their associated 
2 statistics
when cross-tabulated with the incidence of cancer, and the number of
peaks used as input ranged from the best 10 to the best 70. The exact
number of inputs was chosen after testing to find the smallest subset
that would result in the minimum classification error. The choice of 5
hidden-layer neurons was somewhat arbitrary; the performance of
networks with 10 neurons in the hidden layer was also examined but
produced no improvement in predictive accuracy. More fundamen-
tally, the use of a small hidden layer was intended as a defense against
the dangers of over-fitting: with enough inputs and a large enough
hidden layer, a network could be trained to successfully classify any
data set. Given the modest sample size in comparison with the amount
of data collected per subject, it seemed prudent to limit the space of
possible models. Although a 5-hidden-neuron model will fail to cap-
Fig. 4. Examples of spectra illustrating differences between different WCX2 chip batches for a single urine sample 3335. Spectrum A shows the initial result on the chip BB460
run as part of the initial training set using the settings shown in the text. The remaining spectra on chips DU081, AB058, CN651, and DZ145 all from different batches were generated
1 year later using settings that had been adjusted to account for the decay in intensity because of instrument performance with laser intensity of 215 and detector voltage of 2200 V.
6979
SELDI AND NEURAL-NETWORK ANALYSIS OF URINE PROTEINS IN RCCture highly complex interactions between input variables, it also
prevents the detection of spurious interactions through over-fitting to
the training set. (By way of comparison with traditional statistical
techniques, the use of 5 neurons in the hidden layer is roughly
equivalent to limiting a factor analysis or principal components anal-
ysis to the top 5 factors). An element of over-fitting may have
occurred with the artificial neural network, which would account for
the 15% drop in predictive accuracy with the initial blind test samples,
but we feel that this is then unlikely to account for an additional drop
10 months later, although there may be a minor contribution.
Fig. 5. Representative examples of SELDI
WCX2 spectra from urine samples used in the
neural-network training set (laser intensity 210)
and subsequently rerun 18 months later after laser
replacement (laser intensity 190).
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